Can we stop giving preventive antibiotics to transplant patients?
NCT ID NCT07308457
Summary
This study is testing if closely watching patients for signs of infection works as well as giving them a daily preventive antibiotic (ceftriaxone) after a stem cell transplant. It involves 100 adults with blood cancers or other conditions who are receiving a transplant. Researchers want to see which approach leads to fewer infections and complications, especially in hospitals where bacteria are becoming resistant to common drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCIDENCE OF INFECTIOUS DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Uniwersytecki zpital Kliniczny nr 1 im. prof. Tadeusza Sokołowskiego Pomorskiego Uniwersytetu Medycznego w Szczecinie
RECRUITINGSzczecin, West Pomeranian Voivodeship, 71-252, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.